Science Wiki

Flaviviridae (from Latin flavus, meaning "yellow," after its type species, yellow fever virus) is a major family of small (40–60 nm diameter), enveloped, icosahedral-like positive-sense single-stranded RNA (+ssRNA) viruses within the realm Riboviria (order Amarillovirales). Comprising linear, non-segmented genomes of approximately 9.0 to 13.0 kilobases (kb) that encode a single long open reading frame (ORF) translated into one precursor polyprotein, the family Flaviviridae is divided into four ratified genera: Orthoflavivirus (formerly Flavivirus), Hepacivirus, Pestivirus, and Pegivirus. Collectively, members of Flaviviridae infect hundreds of millions of humans and livestock annually, causing clinical syndromes ranging from acute hemorrhagic fevers (dengue virus and yellow fever virus), congenital teratogenicity and Guillain-Barré syndrome (Zika virus), and fatal neuroinvasive meningoencephalitis (West Nile virus, Japanese encephalitis virus, and tick-borne encephalitis virus) to chronic liver cirrhosis and hepatocellular carcinoma (hepatitis C virus).

In 2023, the International Committee on Taxonomy of Viruses (ICTV) renamed the historic genus Flavivirus to Orthoflavivirus to eliminate ambiguity between the genus and the family Flaviviridae. The four genera differ sharply in vector dependence, 5' translation initiation mechanism, and clinical tropism:

Within the genus Orthoflavivirus, phylogenetic and ecological clustering reflects the arthropod vector group:

1. _Aedes_-borne Clade: Associated primarily with diurnal anthropophilic Aedes aegypti and Aedes albopictus in human–mosquito–human urban cycles (and non-human primate sylvatic cycles); causes predominantly viscerotropic, systemic, and hemorrhagic/teratogenic syndromes (dengue, Zika, yellow fever).
2. _Culex_-borne Clade: Associated with ornithophilic Culex mosquitoes in enzootic bird–mosquito amplification cycles where humans and horses are dead-end spillover hosts (because human viremia is too low to infect mosquitoes); causes predominantly neurotropic meningoencephalitis (West Nile, Japanese encephalitis, St. Louis encephalitis, Murray Valley encephalitis, and Usutu viruses).
3. Tick-borne Clade: Transmitted by hard ticks (Ixodes ricinus, Ixodes persulcatus, Dermacentor spp.) with rodent/ungulate reservoirs and transovarial/transstadial tick maintenance (Tick-borne encephalitis, Powassan, Kyasanur Forest disease, and Omsk hemorrhagic fever viruses).

Mature orthoflavivirus virions are spherical, ~50 nm particles consisting of an inner nucleocapsid core (Capsid protein C bound to the +ssRNA genome) surrounded by a host ER-derived lipid bilayer envelope studded with 180 copies of two transmembrane glycoproteins—the Envelope (E) protein (arranged as 90 head-to-tail homodimers lying flat in a herringbone icosahedral lattice) and the small Membrane (M) protein.

Single-Polyprotein Translation and Proteolytic Cleavage

Upon receptor-mediated clathrin-dependent endocytosis (via host attachment factors such as DC-SIGN, TIM/TAM phosphatidylserine receptors, AXL, and heparan sulfate) and low-pH endosomal membrane fusion driven by a conformational trimerization of the E protein, the +ssRNA genome (~10.8 kb) is released directly into the host cytoplasm. Acting immediately as a messenger RNA at rough endoplasmic reticulum (ER) ribosomes, the single open reading frame is translated into one continuous ~3,400-amino-acid polyprotein (~370 kDa):

This precursor polyprotein is co- and post-translationally cleaved at the ER membrane by two proteases—host lumenal signal peptidase (plus Golgi furin) and the viral cytoplasmic NS2B-NS3 serine protease—into three structural proteins and seven nonstructural (NS) proteins:

• Structural Proteins (N-terminal quarter):
• C (Capsid, ~11 kDa): Highly basic homodimer that packages the viral genomic RNA into the nucleocapsid core.
• prM / M (Pre-membrane / Membrane, ~26 kDa → 8 kDa): Chaperones the folding of the E protein inside the ER lumen and prevents premature acid-induced fusion as immature virions traffic through the acidic trans-Golgi network (pH ~6.0). Just prior to exocytosis, the host protease furin cleaves prM into the secreted pr peptide and mature M protein, snapping the 60 trimeric spikes of the immature particle into the smooth, infectious 90-homodimer herringbone lattice.
• E (Envelope, ~53 kDa): Divided into three ectodomains—Domain I (EDI) (central β-barrel hinge), Domain II (EDII) (dimerization domain containing the highly conserved hydrophobic fusion loop at its tip), and Domain III (EDIII) (immunoglobulin-like receptor-binding domain that elicits the most potent type-specific neutralizing antibodies).
• Nonstructural Proteins (C-terminal three-quarters):
• NS1 (~48 kDa): A multifunctional glycoprotein that forms hydrophobic dimers on the ER lumenal membrane to scaffold viral replication vesicles, and is secreted from infected mammalian cells as a soluble lipid-carrying hexamer (sNS1) into the bloodstream. Circulating sNS1 binds Toll-like receptor 4 (TLR4) and degrades the endothelial glycocalyx, directly triggering vascular capillary leakage in severe dengue shock syndrome while serving as the primary rapid diagnostic antigen in clinical lateral-flow tests.
• NS2A, NS2B, NS4A, and NS4B: Hydrophobic transmembrane proteins that remodel the host ER membrane into invaginated vesicle packets (shielding viral dsRNA intermediates from host RIG-I/MDA5 cytosolic sensors), with NS2B serving as the essential cofactor for the NS3 protease.
• NS3 (~70 kDa): A bifunctional enzyme containing an N-terminal chymotrypsin-like serine protease (active as the NS2B-NS3 complex) and a C-terminal RNA helicase / nucleoside 5'-triphosphatase (NTPase) that unwinds dsRNA replication intermediates.
• NS5 (~103 kDa): The largest and most conserved flaviviral protein, containing an N-terminal methyltransferase (MTase) domain (which synthesizes the 5' Type I m⁷GpppAmp RNA cap in orthoflaviviruses) and a C-terminal RNA-dependent RNA polymerase (RdRp) that replicates the viral genome via a negative-sense RNA intermediate, while actively degrading or inhibiting host STAT2 to block Type I interferon signaling.

A defining immunopathological hallmark of the Orthoflavivirus genus—particularly across the four antigenically distinct serotypes of dengue virus (DENV-1, DENV-2, DENV-3, and DENV-4, which share ~65%–70% amino acid identity in their E protein) and between dengue and Zika virus—is Antibody-Dependent Enhancement (ADE), first elucidated by Scott Halstead in the 1970s.

When a person recovers from a primary infection with one dengue serotype (e.g., DENV-1), they generate lifelong high-affinity neutralizing antibodies against DENV-1 (primarily targeting serotype-specific epitopes on EDIII and quaternary dimer epitopes), alongside cross-reactive, weak-affinity antibodies targeting the highly conserved EDII fusion loop and prM uncleaved patches of partially mature virions. If that individual is subsequently infected months or years later by a heterologous serotype (e.g., DENV-2), these preexisting cross-reactive IgG antibodies bind the new virion at sub-neutralizing stoichiometry. Rather than blocking infection, the antibody-coated virion binds FcγIIA and FcγIIIA receptors on the surface of myeloid cells (monocytes, macrophages, and dendritic cells), acting as a "Trojan horse" that internalizes the virus directly into its target cells (extrinsic ADE) while suppressing intracellular RIG-I/MDA5 antiviral signaling and elevating IL-10 (intrinsic ADE). The resulting 10- to 100-fold surge in viremia and NS1 secretion drives a hyper-inflammatory cytokine storm and endothelial barrier breakdown, explaining why secondary heterologous dengue infections carry a 15- to 80-fold higher risk of life-threatening Dengue Hemorrhagic Fever / Dengue Shock Syndrome (DHF/DSS).

1. Licensed Orthoflavivirus Vaccines: Max Theiler's live-attenuated Yellow Fever 17D vaccine (developed in 1937, earning the 1951 Nobel Prize) remains one of the most effective vaccines in medical history, conferring >99% lifelong immunity after a single dose. Effective vaccines are also deployed against Japanese encephalitis (IXIARO, SA14-14-2) and tick-borne encephalitis (FSME-IMMUN). For dengue, tetravalent live-attenuated vaccines (TAK-003 / Qdenga and CYD-TDV / Dengvaxia, plus the Butantan-DV single-dose tetravalent vaccine) must carefully balance neutralizing titers across all four serotypes to avoid vaccine-sensitized ADE in seronegative recipients.
2. Direct-Acting Antivirals (DAAs) for Hepatitis C (Hepacivirus): Whereas no specific small-molecule antiviral is yet approved for orthoflaviviruses, structural characterization of the HCV polyprotein revolutionized hepatology in the 2010s. Combination oral regimens targeting the NS3/4A protease (glecaprevir, voxilaprevir), the NS5A replication complex phosphoprotein (velpatasvir, ledipasvir, pibrentasvir), and the NS5B RNA-dependent RNA polymerase (sofosbuvir, a nucleotide prodrug chain terminator) achieve >97% sustained virologic cure (SVR12) within 8 to 12 weeks—turning a previously incurable chronic Flaviviridae infection into a curable disease.

Why is a second dengue infection often much more dangerous than the first?

Recovery from a first infection with one dengue virus serotype leaves behind cross-reactive antibodies that bind, but cannot neutralize, the other three dengue serotypes. During a secondary infection with a different serotype, these non-neutralizing antibodies attach to the virus and bind Fcγ receptors on human monocytes and macrophages (Antibody-Dependent Enhancement, ADE), helping the virus infect far more immune cells and triggering severe vascular leakage.

How does Hepatitis C virus (HCV) belong to the same family (Flaviviridae) as mosquito-borne dengue and yellow fever?

Although Hepatitis C virus (Hepacivirus) is transmitted strictly via blood-to-blood contact without an insect vector, its genome organization and replication machinery are homologous to mosquito-borne orthoflaviviruses: both are ~10 kb enveloped +ssRNA viruses that translate a single polyprotein cleaved into N-terminal structural proteins (Core, Envelope) and C-terminal nonstructural enzymes (NS2-NS3 protease/helicase and NS5 polymerase) on ER membranes.

Why are humans "dead-end hosts" for West Nile virus and Japanese encephalitis virus, but amplifying hosts for dengue and Zika?

When dengue, Zika, or yellow fever viruses infect humans, they replicate to high titers in the bloodstream (10⁶ to 10⁹ RNA copies/mL), allowing biting Aedes mosquitoes to easily acquire the virus. In contrast, West Nile and Japanese encephalitis viruses are adapted to birds; in humans, viremia remains so low (<10³ copies/mL) and brief that a feeding Culex mosquito cannot ingest an infectious dose.